Metabolism-based cardiomyocytes production for regenerative therapy

TC Umei, S Tohyama, K Fukuda - Journal of Molecular and Cellular …, 2023 - Elsevier
Human pluripotent stem cells (hPSCs) are currently used in clinical applications such as
cardiac regenerative therapy, studying disease models, and drug screening for heart failure …

Metabolism-based cardiomyocytes production for regenerative therapy

TC Umei, S Tohyama, K Fukuda - Journal of molecular …, 2023 - pubmed.ncbi.nlm.nih.gov
Human pluripotent stem cells (hPSCs) are currently used in clinical applications such as
cardiac regenerative therapy, studying disease models, and drug screening for heart failure …

Metabolism-based cardiomyocytes production for regenerative therapy

TC Umei, S Tohyama, K Fukuda - Journal of Molecular and …, 2023 - keio.elsevierpure.com
Human pluripotent stem cells (hPSCs) are currently used in clinical applications such as
cardiac regenerative therapy, studying disease models, and drug screening for heart failure …

[引用][C] Metabolism-based cardiomyocytes production for regenerative therapy

遠山周吾 - Journal of Molecular and Cellular Cardiology, 2023 - cir.nii.ac.jp
Metabolism-based cardiomyocytes production for regenerative therapy | CiNii Research CiNii
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

[引用][C] Metabolism-based cardiomyocytes production for regenerative therapy

TC Umei, S Tohyama, K Fukuda - Journal of Molecular and Cellular …, 2023 - cir.nii.ac.jp
Metabolism-based cardiomyocytes production for regenerative therapy | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

Metabolism-based cardiomyocytes production for regenerative therapy

TC Umei, S Tohyama, K Fukuda - Journal of Molecular and …, 2023 - keio.elsevierpure.com
抄録 Human pluripotent stem cells (hPSCs) are currently used in clinical applications such
as cardiac regenerative therapy, studying disease models, and drug screening for heart …